Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SERAX

OXAZEPAM

Standard Dose
10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SERAX is listed in Drugs@FDA under application 015539 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient OXAZEPAM Form and strength CAPSULE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALPHARMA US PHARMS Submission history Latest submission status date: 2001-11-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview SERAX is listed in Drugs@FDA under application 015539 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient OXAZEPAM Form and strength CAPSULE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor ALPHARMA US PHARMS Submission history Latest submission status date: 2001-11-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
SERAX (OXAZEPAM) | Drug Monograph | MedicHelpline